Plato Investment Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.07M Buy
22,412
+599
+3% +$205K 0.46% 42
2026
Q1
$7.68M Buy
21,813
+1,388
+7% +$495K 0.52% 39
2025
Q4
$6.72M Buy
20,425
+121
+0.6% +$38.4K 0.44% 46
2025
Q3
$5.69M Buy
20,304
+2,258
+13% +$655K 0.39% 50
2025
Q2
$5.02M Buy
18,046
+983
+6% +$278K 0.38% 57
2025
Q1
$5.37M Sell
17,063
-3,091
-15% -$913K 0.45% 39
2024
Q4
$5.27M Buy
20,154
+1,446
+8% +$429K 0.39% 55
2024
Q3
$6.02M Buy
18,708
+735
+4% +$240K 0.49% 40
2024
Q2
$5.62M Buy
17,973
+885
+5% +$260K 0.52% 37
2024
Q1
$4.86M Buy
17,088
+13,845
+427% +$4.05M 0.5% 41
2023
Q4
$934K Buy
+3,243
New +$884K 1.15% 14

Other funds holding AMGN

Plato Investment Management's AMGN Position: Q2 2026 in Review

Plato Investment Management increased its Amgen (AMGN) stake by 2.7% in Q2 2026, buying an estimated $205K and bringing the position to 22,412 shares worth $8.07M. The position accounts for 0.46% of the portfolio, ranked #42.

Plato Investment Management first reported a position in AMGN in Q4 2023 and has held it in 11 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Plato Investment Management held 22,412 shares of Amgen worth $8.07M as of Q2 2026.
  • Plato Investment Management bought 599 Amgen shares in Q2 2026, an estimated $205K.
  • Amgen made up 0.46% of Plato Investment Management's portfolio in Q2 2026, its #42 holding.
  • Plato Investment Management first reported a position in Amgen in Q4 2023 and has held it in 11 quarters since.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Plato Investment Management's 13F filing for Q2 2026, filed 7 Aug 2026.